Letter to the Editor

Page 3

PCC
Comment on Huntington’s Disease With Psychotic Features
Letter to the Editor

March 7, 2023

Herwig Lange, MD, comments on a report previously published in the PCC.
PCC
State of the Art of Diagnostics and Genetics in Huntington’s Chorea
Letter to the Editor

March 7, 2023

Mayank Gupta, MD, and Christoph U. Correll, MD, respond to Herwig Lange, MD, regarding their previous case report of a patient with Huntington’s disease.
,
PCC
Buprenorphine Maintenance in the Fentanyl Era
Letter to the Editor

February 14, 2023

Methods to foster patient adherence and physician acceptability of buprenorphine maintenance are needed to incorporate this treatment into primary care for fentanyl users.
,
JCP
Possible Suicidal Risk With Daridorexant
Letter to the Editor

December 7, 2022

Instructions for use of the new anti-insomnia medication daridorexant mention cautious use in patients with history of suicidal behavior. This letter explores the factors that underlie this recommendation for...
, ,
JCP
Pregnancy Outcomes After SGA Exposure: Extracting More From the Data
Letter to the Editor

November 30, 2022

Malathi Perugula, MD, and colleagues call attention to design aspects of a recent study on antipsychotic use in pregnancy.
, , , et al
JCP
Reply to Perugula et al: Toward Improving Reliability of Safety Information on Drug Exposure in Pregnancy
Letter to the Editor

November 30, 2022

Naho Yakuwa, BPharm, responds to Perugula and colleagues about a recent study on SGA use during early pregnancy.
JCP
Stigma Kills Psychiatric Patients and Is Now Killing Clinical Research Too
Letter to the Editor

November 28, 2022

Robert M. Post, MD, argues that NIMH should abandon the RDoC framework and restore funding for clinical research.
JCP
Valproate Prescribing in Individuals of Childbearing Age
Letter to the Editor

October 12, 2022

Camille Tastenhoye, MD, and colleagues share data from a tertiary care women’s hospital that highlight opportunities for improvement in valproate prescribing practices.
, , , et al
JCP
Addressing the Problem of Prescription of Valproate to Women of Childbearing Age: Reply to Tastenhoye et al
Letter to the Editor

October 12, 2022

Chittaranjan Andrade, MD, responds to a letter by Tastenhoye et al and comments on his recent study on valproate prescription in women.
JCP
Asenapine, Aggression, and Affinity
Letter to the Editor

September 28, 2022

Dr El-Mallakh comments on a recent study by Citrome et al and discusses his group’s research on antiaggression effects of clozapine.
JCP
A Mirror-Image Trial or Smoke and Mirrors? Phase 3b Study on Digital Aripiprazole
Letter to the Editor

August 3, 2022

This letter comments on methodological aspects of a recent study by Cohen et al.
, , , et al
PCC
Mental Well-Being of Health Care Workers During the COVID-19 Pandemic
Letter to the Editor

July 19, 2022

Here, the authors discuss the psychological impact of working during the pandemic on health care workers in Northern Italy.
, , , et al
PCC
Mindfulness Training in Opioid Withdrawal
Letter to the Editor

June 30, 2022

In this letter to the editor, the authors comment on an article published recently in the PCC.
, ,
JCP
Corrigendum to “Decreases in Suicidality Following Psychedelic Therapy: A Meta-Analysis of Individual Patient Data Across Clinical Trials”
Letter to the Editor

May 9, 2022

The authors note two suicidality-related events that occurred within the studies included in their recent meta-analysis.
, , , et al
JCP
Peer-Delivered Psychotherapy for Postpartum Depression: Reply to Tomfohr-Madsen et al
Letter to the Editor

April 27, 2022

Dr O’Hara responds to a letter regarding his recent commentary on peer-delivered psychotherapy.
JCP
Peer-Led Psychotherapy: The Time Is Now
Letter to the Editor

April 27, 2022

Tomfohr-Madsen et al respond to O’Hara’s recent commentary on peer-delivered psychotherapy for postpartum depression.
, , , et al
JCP
Twelve-Month Outcomes for Remitters Following ECT for Depression
Letter to the Editor

April 18, 2022

Jelovac and McLoughlin respond to Dr Andrade’s recent Clinical and Practical Psychopharmacology article commenting on their study of maintenance ECT.
,
JCP
Research Design and Overfitting: Reply to Jelovac and McLoughlin
Letter to the Editor

April 18, 2022

Dr Andrade responds to a comment from the authors of a study mentioned in his recent article on maintenance ECT.
PCC
The Hidden Curriculum in Addiction Training
Letter to the Editor

March 24, 2022

In this letter to the editor, the authors discuss the stigma associated with addiction treatment, as well as strategies to increase addiction literacy among physicians.
,
JCP
Conflating Capacity and Compliance
Letter to the Editor

February 1, 2022

Commenting on a recent JCP editorial, the authors discuss decision-making capacity as it relates to COVID-19 vaccine refusal.
,
JCP
Recognizing Impaired Decisional Capacity in Vaccine Refusal: Reply to Kels and Kels
Letter to the Editor

February 1, 2022

The authors reply to a letter commenting on Dr Goldberg’s JCP editorial examining COVID-19 vaccine hesitancy.
,
JCP
Letter to the Editor

December 7, 2021

Lambrichts and colleagues respond to Dr Andrade’s recent Clinical and Practical Psychopharmacology article commenting on their study of maintenance ECT.
, , , et al
JCP
Letter to the Editor

December 7, 2021

Dr Andrade responds to a comment from the authors of a study mentioned in his recent article on maintenance ECT.
JCP
Letter to the Editor

October 19, 2021

The authors reply to a letter commenting on their recent JCP article on the prevalence of perinatal OCD.
,

Celebrating
85 Years

Read the Journal of Clinical Psychiatry

Subscribe to read
more articles

Subscribe